Oxygen Therapy Guidelines for Managing Dropping Oxygen Saturation

Introduction to Oxygen Therapy

The American Thoracic Society recommends oxygen therapy for patients with hypoxemia, with target SpO2 ranges of 94-98% for most patients 1, 6
For patients at risk of hypercapnic respiratory failure, the target SpO2 range is 88-92% 1, 6

Initial evaluation of dropping SpO2 should include verification of the reading, clearing airway secretions, and assessing respiratory rate, heart rate, and work of breathing 4, 5
Patients at risk for hypercapnic respiratory failure include those with moderate to severe COPD, severe chest wall or spinal disease, neuromuscular disease, severe obesity, and cystic fibrosis or bronchiectasis 6, 7

For patients not at risk of hypercapnic respiratory failure, oxygen therapy should be started with a target SpO2 range of 94-98% 1, 6
For patients at risk of hypercapnic respiratory failure, oxygen therapy should be started with a target SpO2 range of 88-92% and arterial blood gas analysis should be obtained to assess PaCO2 6, 3
The British Thoracic Society recommends adjusting oxygen delivery device and flow rate if target range cannot be maintained 6

Premature infants and those with bronchopulmonary dysplasia or congenital heart disease require closer monitoring during oxygen therapy 8, 4
Patients with paraquat poisoning or bleomycin lung injury may be harmed by supplemental oxygen, with a target SpO2 of 85-88% 2
The American Academy of Pediatrics recommends maintaining higher SpO2 targets for patients with fever, acidosis, or hemoglobinopathies due to shifts in the oxyhemoglobin dissociation curve 4

Continuous monitoring of SpO2 is recommended after initiating oxygen therapy 6
Non-invasive ventilation (NIV) should be considered for patients with persistent hypoxemia despite oxygen therapy, especially those with COPD exacerbations or cardiogenic pulmonary edema 6, 3